Neurocrine Biosciences Inc

XMUN:NB3

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is NB3's stock price target?

Price Target

173.04 EUR

According to Wall Street analysts, the average 1-year price target for NB3 is 173.04 EUR with a low forecast of 128.36 EUR and a high forecast of 227.96 EUR.

What is the Revenue forecast for Neurocrine Biosciences Inc?

Projected CAGR

13%

Over the last 13 years, the compound annual growth rate for Revenue has been 36%. The projected CAGR for the next 8 years is 13%.

What is the Gross Profit forecast for Neurocrine Biosciences Inc?

Projected CAGR

13%

The compound annual growth rate for Gross Profit over the next 8 years is 13%.

What is the Operating Income forecast for Neurocrine Biosciences Inc?

Projected CAGR

26%

Over the last 13 years, the compound annual growth rate for Operating Income has been 53%. The projected CAGR for the next 8 years is 26%.

What is the Pre-Tax Income forecast for Neurocrine Biosciences Inc?

Projected CAGR

38%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 46%. The projected CAGR for the next 3 years is 38%.

What is the Net Income forecast for Neurocrine Biosciences Inc?

Projected CAGR

30%

Over the last 13 years, the compound annual growth rate for Net Income has been 42%. The projected CAGR for the next 8 years is 30%.